Study directory

Mental health studies with practical context.

Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.

Back to overview
23847studies shown
Showing 301-312 of 23,847
Drug study icon
RecruitingNCT03423680

Abilify® Tablet(Aripiprazole) for depression in bipolarity

This study is recruiting in South Korea. It is testing abilify® Tablet(Aripiprazole) for depression in bipolarity.

In Seoul
Bipolarity, DepressionDrugA study involving a medication or substance.From 19 Years to 70 Years
Countries
South Korea
Sponsor
Korea Otsuka Pharmaceutical Co., Ltd.
Condition
Bipolarity, Depression
Drug study icon
RecruitingNCT07286175

Brenipatide in adults with Bipolarity (RENEW-Bipolar-1)

This study is recruiting in the United States, in Argentina, in Brazil, .... It is testing brenipatide for Bipolarity.

Multiple locations, including Orange
BipolarityDrugFrom 18 Years to 75 Years
Countries
United States, Argentina, Brazil, ...
Sponsor
Eli Lilly and Company
Condition
Bipolarity
Drug study icon
RecruitingNCT07412756

Brenipatide in adults with Major Depressive Disorder

This study is recruiting in the United States, in Australia, in Canada, .... It is testing brenipatide for depression.

Multiple locations, including Moorpark
DepressionDrugFrom 18 Years to 75 Years
Countries
United States, Australia, Canada, ...
Sponsor
Eli Lilly and Company
Condition
Depression
Drug study icon
RecruitingNCT07410507

Brenipatide in adults with Schizophrenia

This study is recruiting in the United States, in Argentina, in Brazil, .... It is testing brenipatide for schizophrenia.

Multiple locations, including Little Rock
SchizophreniaDrugFrom 18 Years to 55 Years
Countries
United States, Argentina, Brazil, ...
Sponsor
Eli Lilly and Company
Condition
Schizophrenia
Drug study icon
RecruitingNCT07420283

Brenipatide in people with Addiction

This study is recruiting in the United States, in Canada, and in the United Kingdom. It is testing brenipatide for Addiction.

Multiple locations, including Phoenix
AddictionDrugFrom 18 Years to 75 Years
Countries
United States, Canada, United Kingdom
Sponsor
Eli Lilly and Company
Condition
Addiction
Drug study icon
RecruitingNCT07219953

Brenipatide in people with Addiction

This study is recruiting in the United States, in the United Kingdom, in Belgium, .... It is testing brenipatide for Addiction.

Multiple locations, including Scottsdale
AddictionDrugFrom 18 Years to 75 Years
Countries
United States, United Kingdom, Belgium, ...
Sponsor
Eli Lilly and Company
Condition
Addiction
Drug study icon
RecruitingNCT07219966

Brenipatide in people with Moderate-to-Severe Addiction

This study is recruiting in the United States, in the United Kingdom, in Belgium, .... It is testing brenipatide for Addiction.

Multiple locations, including Birmingham
AddictionDrugFrom 18 Years to 75 Years
Countries
United States, United Kingdom, Belgium, ...
Sponsor
Eli Lilly and Company
Condition
Addiction
Behavioral study icon
RecruitingNCT05574127

Brief Behavioral Activation for depression

This study is recruiting in the United States. It is testing brief Behavioral Activation for depression.

In New York
DepressionBehavioralOver 65 Years
Countries
United States
Sponsor
Memorial Sloan Kettering Cancer Center
Condition
Depression
Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.